Stern Future Healthcare Workforce Summit

Currently the Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU School of Medicine in New York City.

Prior to coming to NYU School of Medicine, Dr. Caplan was the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania Perelman School of Medicine in Philadelphia, where he created the Center for Bioethics and the Department of Medical Ethics. Caplan has also taught at the University of Minnesota, where he founded the Center for Biomedical Ethics, the University of Pittsburgh, and Columbia University.  He received his PhD from Columbia University.

Dr. Caplan is the author or editor of thirty-five books and over 865 papers in peer reviewed journals. His most recent books are Vaccination Ethics and Policy, with Jason Schwartz and, Getting to Good: Research Integrity in Biomedicine with Barbara Redman.

He has served on a number of national and international committees including as the chair of the National Cancer Institute Biobanking Ethics Working Group, chair of the Advisory Committee to the United Nations on Human Cloning; chair of the Advisory Committee to the Department of Health and Human Services on Blood Safety and Availability. He has also served on the Presidential Advisory Committee on Gulf War Illnesses, the special advisory committee to the International Olympic Committee on genetics and gene therapy, the Special Advisory Panel to the National Institutes of Mental Health on Human Experimentation on Vulnerable Subjects, the Wellcome Trust Advisory Panel on Research in Humanitarian Crises, and the co-director of the Joint Council of Europe/United Nations Study on Trafficking in Organs and Body Parts. He is currently a member of the National Academy of Science and Medicine’s expert advisory committee on hand and face transplantation.

Caplan has served since 2015 as the co-chairperson of the Compassionate Use Advisory Committee (CompAC), an independent group of internationally recognized medical experts, bioethicists and patient representatives which advises Johnson & Johnson’s Janssen Pharmaceuticals about requests for compassionate use of some of its investigational medicines.

Dr. Caplan is a regular commentator on bioethics and health care issues for WebMD/Medscape, WGBH radio in Boston, WOR radio in New York City and KNX-CBS radio, Los Angeles.  He appears frequently as a guest and commentator on various other national and international media outlets.

Dr. Caplan is the recipient of many awards and honors including the McGovern Medal of the American Medical Writers Association and the Franklin Award from the City of Philadelphia. He was a USA Today 2001 “Person of the Year and was described as one of the ten most influential people in science by Discover magazine in 2008.

He has also been honored as one of the fifty most influential people in American health care by Modern Health Care magazine, one of the ten most influential people in America in biotechnology by the National Journal, one of the ten most influential people in the ethics of biotechnology by the editors of Nature Biotechnology, and one of the 100 most influential people in biotechnology by Scientific American magazine.

During the Covid-19 pandemic, he co-directed an advisory group on sports and recreation for the US Conference of Mayors, created a national working group on coronavirus vaccine challenge studies, developed an ethical framework for distributing drugs and vaccines for J&J, helped develop rationing policies for NYU LMC and many other health systems, was a member of the WHO advisory committee on Covid, ethics and experimental drugs/vaccines, and helped set policy for WIRB/WCG for research studies He was an advisor to Moderna and Accenture.  And he served on the NCAA Sports and Covid committee.

He received the Patricia Price Browne Prize in Biomedical Ethics for 2011. In 2014 he was selected to receive the Public Service Award from the National Science Foundation/National Science Board, which honors individuals and groups that have made substantial contributions to increasing public understanding of science and engineering in the United States. In 2016 the National Organization for Rare Disorders (NORD) honored him with their Rare Impact Award and Food and Drug Law Institute’s Distinguished Service Leadership Award. In 2019 he was honored by the Food and Drug Administration’s, Reagan/Udall Foundation with its Innovation Award.NYU Rory Meyers College of Nursing Humanitarian Award. In 2024 he was honored as the mentor of the year by the NYUGSOM Department of Population Health.

He holds eight honorary degrees from colleges, universities and medical schools.

Dr. Dan Weberg is a Fellow of the American Academy of Nursing as well as an expert in, healthcare innovation, leadership and human-centered design. He has extensive clinical experience in emergency departments, acute in-patient hospital settings and academia. Dan has also consulted across several organizations to support strategy and innovation ecosystems to improve healthcare.

Currently, Dan serves as the Executive Director of Nursing Workforce Development and Innovation at Kaiser Permanente, where he returned in May 2023. He supports the growth of over 800 new graduate nurses across all 8 markets of KP, develops workforce strategy, and supports the career and professional growth of over 70,000 nurses and leaders.

He served as the Vice President for Transformation Services at Ascension, supporting 60,000 nurses and 140+ facilities in modernizing nursing technology, developing new care models, and measuring innovation outcomes.

Previously he was Head of Clinical Innovation for Trusted Health, the staffing platform for the healthcare industry, where he helped drive product strategy and worked to change the conversation around innovation in the healthcare workforce.

Dan spent seven years at Kaiser Permanente, where he held executive roles in nursing innovation, research, and technology strategy across eight markets and 40 hospitals. He was also part of the founding faculty for the new Kaiser Permanente School of Medicine.

Dan is on the faculty at The Ohio State University College of Nursing and multiple innovation fellowship programs. He previously taught on nursing innovation and leadership at Arizona State University. He is on the editorial board for Nursing Administration Quarterly and has authored two dozen peer-reviewed articles and two textbooks, including Evidence Based Innovation Leadership for Health Professions and Leadership in Nursing Practice.

Dan earned his Bachelors in Nursing, and was in the first cohort to graduate from the Masters in Healthcare Innovation program at ASU, as well as the first-ever graduate of the PhD in Healthcare Innovation Leadership program at ASU. Dan serves on several advisory boards, including the American Nurses Association Innovation Advisory Board. His clinical background is in Emergency and Trauma nursing at level 1 trauma centers in California and Arizona.

Alex Goryachev is a globally recognized expert in AI-driven workplace transformation and an influential keynote speaker on innovation. 

With a leadership track record at iconic brands like Cisco, IBM, Dell, and Pfizer, Alex is renowned for helping organizations harness the power of AI to achieve strategic growth. 

As the former Managing Director and Global Head of Innovation Strategy at Cisco, he established Innovation Centers across five continents and led the launch of Cisco’s groundbreaking AI innovation program, positioning the company at the forefront of AI advancements.

Throughout his career, Alex spearheaded transformational initiatives such as Smart City strategies in seven countries, innovation tracks for three Olympic Games, and rolled out innovation and emerging technologies learning programs to nearly 300,000 students. 

His leadership in driving employee-led innovation earned Cisco Forbes' title of "#1 Best Place to Work for Innovators," solidifying his reputation as a catalyst for organizational change. Alex’s presentations and workshops have helped hundreds of organizations navigate AI, transforming their workplace culture for sustained success and growth.

Driving the future of innovation, Alex Goryachev is a key force behind the global ISO Standards on Innovation. As a WSJ bestselling author and a frequent contributor to Fast Company, Forbes, and Entrepreneur, Alex is at the forefront of the AI revolution, shaping the future while developing tomorrow's leaders. In his role as Executive-in-Residence at Tulane University’s Center for Entrepreneurship and Innovation, he shares his expertise with emerging leaders. A recognized authority on workplace transformation, Alex continues to inspire and guide organizations through rapid change. Alex has received numerous awards for his contributions to innovation and culture change. With over 250 dynamic presentations delivered to Fortune 500 companies, startups, non-profits, universities, and governments worldwide, his candid, thought-provoking keynotes demystify AI, offering actionable steps to help organizations lead in workplace transformation and innovation.